Shanghai - Seattle - Boston | U.S.A.
| Investor Type | Firm |
| Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine) |
| Stages | Seed, Series A, Series B |
| Investing | United States • United Kingdom • Portugal |
| Investment Range | $100,000 - $5,000,000 |
| Investment Sweet Spot | $1,500,000 |
About The Fund
Apple Tree Partners (ATP) is an investment fund specializing in the life sciences sector, with a clear focus on identifying and nurturing innovative ventures in BioTech, HealthTech (& Fitness), Medical Devices (& Hospital Services), Healthcare (& Wellness), and Pharmaceutical (& Medicine) industries. Pioneered by Seth L. Harrison, ATP has been investing in life sciences since 1999, and the team, carrying significant expertise, reflects a commitment to driving advancements in healthcare and life sciences. ATP provides seed to Series B funding, with investments ranging from $100,000 to $5,000,000, and a sweet spot of around $1,500,000 for fostering companies at critical stages of development. The team is composed of experienced leaders and experts, including venture partners, entrepreneurs in residence, and a chief medical officer, who bring together a deep understanding of drug and product development, scientific research, and business strategy to build successful biopharmaceutical and medical ventures. Notable portfolio companies and board involvements span a wide array of life sciences innovations, reflecting ATP's commitment to diverse therapeutic areas and technologies. Some board responsibilities include Aethon Therapeutics, Akero Therapeutics, Apertor Pharmaceuticals, Ascidian Therapeutics, Aulos Bioscience, Braeburn, Deep Apple Therapeutics, Evercrisp Biosciences, Galvanize Therapeutics, Initial Therapeutics, Marengo Therapeutics, Marlinspike Therapeutics, Nereid Therapeutics, Nine Square Therapeutics, Red Queen Therapeutics, Replicate Bioscience, and Stoke Therapeutics, evidencing the extensive scope of ATP’s influence in shaping the life sciences landscape. The collective experience of ATP's team, catalyzing the inception and growth of medical innovation, exemplifies their investment thesis focused on pioneering treatments that can significantly impact patient care and the medical field as a whole. Through strategic guidance, hands-on leadership, and a deep network of industry relationships, ATP not only funds but actively participates in the cultivation of cutting-edge science and promising therapeutic ventures.
ATP (Apple Tree Partners)'s investments on record
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
e
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 85 Great Portland St.
- London, U.K.
- contact@angelspartners.com
